Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
OTS167
i
Other names:
OTS 167, OTS167PO, OTS167, OTSSP167, OTS167IV, OTS-167
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
OncoTherapy
Drug class:
MELK inhibitor
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
OTS167
Sensitive: D – Preclinical
OTS167
Sensitive
:
D
OTS167
Sensitive: D – Preclinical
OTS167
Sensitive
:
D
TRAF1 overexpression
Chronic Lymphocytic Leukemia
TRAF1 overexpression
Chronic Lymphocytic Leukemia
venetoclax + OTS167
Sensitive: D – Preclinical
venetoclax + OTS167
Sensitive
:
D
venetoclax + OTS167
Sensitive: D – Preclinical
venetoclax + OTS167
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.